GLP-1s are linked to a 17% drop in worker sick leave, new study finds
Summary
A new study shows that GLP-1 drugs, like Ozempic and Wegovy, help reduce long-term sick leave by 17% among workers. This decrease could save money for workers, employers, and the government by lowering time off due to illness.Key Facts
- GLP-1 drugs are prescribed for diabetes and obesity and improve health by lowering risks of heart attacks and strokes.
- The study found users of GLP-1 drugs took 17% less sick leave lasting over 30 days than non-users.
- Reduced sick leave can save up to 1.5% of an individual’s salary, about $866 on average.
- The research used data from Denmark, where employers pay full salary for up to 30 days of sick leave, and the government pays after that.
- Short-term sick leave reductions save employers money, while long-term reductions save the government money in Denmark.
- In the U.S., sick leave policies are less generous, so reduced sick leave might improve worker productivity and benefit companies.
- The study suggests that fewer sick days and less “presenteeism” (working while sick and less effective) could lead to better job performance and career opportunities.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
